Ocean View, Delaware, March 20, 2017 (GLOBE NEWSWIRE) --
The trends outlook report “Molecular Diagnostics Market Size By Infectious Disease (Flu, Tuberculosis, Meningitis, RSV Virus, Hepatitis B, Hepatitis C, HPV, STD, HIV, Dengue, Gonorrhea, Chlamydia, TORCH, H. Pylori), By Technology (PCR, Real-Time PCR, DNA/RNA Purification), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Portugal, Italy, Russia, Denmark, Norway, Sweden, Israel, Japan, China, India, Sri Lanka, Pakistan, Philippines, South Korea, Australia, New Zealand, Vietnam, Thailand, Mexico, Brazil, Argentina, Colombia, Chile, Peru, South Africa, Nigeria, Morocco, Egypt, KSA, UAE, Jordan, Qatar), Application Potential, Price Trend, Competitive Market Share & Forecast, 2016 - 2023” by Global Market Insights, Inc. says Molecular Diagnostics Market size will exceed USD 10 billion by 2023.
Increasing geriatric population and associated rise in chronic disease prevalence will drive global molecular diagnostics market size. According to UN estimates, population with more than 65 years of age should witness substantial increase from 901 million in 2015 to 2.1 billion by 2050.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/434
Emergence of technologically advanced diagnostic products should offer promising market growth opportunities for industry players. Furthermore, growing demand for point of care diagnostics (PoC) will accelerate molecular diagnostics market growth. Growing adoption of personalized medicines and companion diagnostics, improved acceptance of diagnostic devices by healthcare practitioners, and increasing research funding to conduct medical diagnostics clinical studies, should propel growth.
HPV is anticipated to expand at impressive 9.8% CAGR from 2016 to 2023. Growing HPV prevalence should provide lucrative market expansion opportunities to industry participants. As per CDC, around 79 million people are infected with HPV in the U.S. alone. Sexually Transmitted Diseases held majority of molecular diagnostics market share, with more than USD 1 billion in 2015.
PCR held more than 45% of molecular diagnostics market share in 2016. Emergence of new technologies such as genetic sequencing and in-situ hybridization should hinder growth over the forecast period.
U.S. molecular diagnostics market size should surpass USD 4 billion by 2023 owing to improved healthcare infrastructure, high technology adoption and increased patient awareness regarding early disease diagnosis. India molecular diagnostics market size should manifest robust growth attributed to huge patient numbers suffering from infectious diseases, effective preventive healthcare policies, rapid economic development and improvement in healthcare infrastructure throughout the country.
Key industry participants include Alere, Abbott Laboratories, Becton Dickinson, Bayer Healthcare, Bio-Rad Laboratories, bioMerieux, Cepheid, Dako, Hologic (Gen Probe), Danaher Corporation, Johnson & Johnson, Qiagen, Novartis (Grifols), Siemens Healthcare, Roche Diagnostics and Sysmex.
Browse key industry insights spread across 115 pages with 142 market data tables & 9 figures & charts from the report Molecular Diagnostics Market in detail along with the table of contents at:
https://www.gminsights.com/industry-analysis/molecular-diagnostics-market-report
U.S. molecular diagnostics market share drives the regional industry, with expectations to exceed USD 4.2 billion by 2023. The factors contributing to revenue growth includes rising technological advancements, increasing patient awareness levels, improved healthcare infrastructure and growing R&D activities pertaining to drug discovery.
China molecular diagnostics market size is anticipated to witness positive trend owing to increasing investments in developing healthcare infrastructure and favorable government policies promoting preventive healthcare through diagnostic testing. Malaysia revenue share is anticipated to grow over forecast period owing to rising prevalence of infectious diseases such as dengue, leptospirosis, and diarrhea.
Product portfolio expansion and strategic collaborations should be resorted as primary competitive strategies by industry participants to hold their respective business shares.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/434
Molecular Diagnostics market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2012 to 2023, for the following segments:
Molecular Diagnostics Market Infectious Disease Analysis
- Flu
- Tuberculosis
- Meningitis
- RSV Virus
- Hepatitis B
- Hepatitis C
- HPV
- STD
- HIV
- Dengue
- Gonorrhea
- Chlamydia
- TORCH
- H. Pylori
Molecular Diagnostics Market Technology Analysis
- PCR
- Real-Time PCR
- DNA/RNA Purification
The above information is provided for the following regions and countries:
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Portugal
- Italy
- Russia
- Denmark
- Norway
- Sweden
- Israel
- Asia Pacific
- China
- Japan
- India
- Srilanka
- Malaysia
- Pakistan
- Philippines
- South Korea
- Australia
- New Zealand
- Vietnam
- Thailand
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Peru
- MEA
- South Africa
- Nigeria
- UAE
- Jordan
- Qatar
- Morocco
- Egypt
- Saudi Arabia
Browse Related Reports:
- Autoimmune Disease Diagnostics Market Size By Product [Systemic (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus (SLE)), Localized], Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, U.K, Japan, China, Brazil) Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023
https://www.gminsights.com/industry-analysis/autoimmune-disease-diagnostics-market
- HIV Diagnostics Market Size By Product [Antibody Tests (HIV-1 Screening, ELISA/EIA, Home Access Dried Blood Spot, Rapid Test, HIV-1 Confirmatory Steps, Western Blot, Indirect Immunoflorescent Antibody Assay (IIFA), Line Immunoassay , RadioImmuno Precipitation Assay (RIPA), HIV-2 & Group O Test, Blood Antibody, Dried Blood Spot), Viral Identification Assay (p24 Antigen, Qualitative PCR, Viral Culture), CD4, Viral Load, Early Infant Diagnosis], Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, Japan, China, South Africa, Brazil), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023
https://www.gminsights.com/industry-analysis/hiv-diagnostics-market
About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter